PHE885 CAR-T Therapy

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PHE885 CAR-T Therapy, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma [Phase 2]